Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes

Debdulal Chakraborty,1 Aniruddha Maiti,2 Jay U Sheth,3 Soumen Mondal,1 Subhendu Boral,1 Krishnendu Nandi,4 Tushar Kanti Sinha,1 Arnab Das1 1Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India; 2Department of Vitreoretinal Services, Global Eye Hospitals Eye, Kolkata...

Full description

Bibliographic Details
Main Authors: Chakraborty D, Maiti A, Sheth JU, Mondal S, Boral S, Nandi K, Sinha TK, Das A
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:Clinical Ophthalmology
Subjects:
brolucizumab
inflammation
age related macular degeneration
Online Access:https://www.dovepress.com/brolucizumab-in-neovascular-age-related-macular-degeneration--indian-2-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/brolucizumab-in-neovascular-age-related-macular-degeneration--indian-2-peer-reviewed-fulltext-article-OPTH

Similar Items